ArticleFrontiers in immunology2026

Identification of predictive biomarkers and dose optimization for camrelizumab combined with apatinib in the treatment of advanced hepatocellular carcinoma: a quantitative systems pharmacology approach.

Weikun Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.